Switch theme
Sign up to access all valuation multiples
Voronoi Inc is a biotech company that develops novel kinase inhibitors and targets protein degraders.
2015
n/a
LTM Revenue $11.1M
LTM EBITDA -$17.5M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Voronoi has a last 12-month revenue (LTM) of $11.1M and a last 12-month EBITDA of -$17.5M.
In the most recent fiscal year, Voronoi achieved revenue of n/a and an EBITDA of -$21.9M.
Voronoi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Voronoi valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $11.1M | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | $11.1M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$17.5M | XXX | -$21.9M | XXX | XXX | XXX |
| EBITDA Margin | -157% | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$18.7M | XXX | -$26.4M | XXX | XXX | XXX |
| EBIT Margin | -168% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$16.8M | XXX | -$23.7M | XXX | XXX | XXX |
| Net Margin | -151% | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Voronoi's stock price is KRW 105700 (or $77).
Voronoi has current market cap of KRW 1.90T (or $1.4B), and EV of KRW 1.85T (or $1.3B).
See Voronoi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.4B | XXX | XXX | XXX | XXX | $-0.92 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Voronoi has market cap of $1.4B and EV of $1.3B.
Voronoi's trades at n/a EV/Revenue multiple, and -61.6x EV/EBITDA.
Equity research analysts estimate Voronoi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Voronoi has a P/E ratio of -82.3x.
See valuation multiples for Voronoi and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 121.2x | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -77.1x | XXX | -61.6x | XXX | XXX | XXX |
| EV/EBIT | -72.3x | XXX | -51.0x | XXX | XXX | XXX |
| EV/Gross Profit | 121.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | -82.3x | XXX | -58.2x | XXX | XXX | XXX |
| EV/FCF | -92.4x | XXX | -61.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVoronoi's last 12 month revenue growth is 182%
Voronoi's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Voronoi's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Voronoi's rule of X is 298% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Voronoi and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 182% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -157% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | -64% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 298% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Voronoi acquired XXX companies to date.
Last acquisition by Voronoi was XXXXXXXX, XXXXX XXXXX XXXXXX . Voronoi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Voronoi founded? | Voronoi was founded in 2015. |
| Where is Voronoi headquartered? | Voronoi is headquartered in South Korea. |
| Who is the CEO of Voronoi? | Voronoi's CEO is Mr. Hyun-Tae Kim. |
| Is Voronoi publicy listed? | Yes, Voronoi is a public company listed on KRX. |
| What is the stock symbol of Voronoi? | Voronoi trades under 310210 ticker. |
| When did Voronoi go public? | Voronoi went public in 2022. |
| Who are competitors of Voronoi? | Similar companies to Voronoi include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Voronoi? | Voronoi's current market cap is $1.4B |
| What is the current revenue of Voronoi? | Voronoi's last 12 months revenue is $11.1M. |
| What is the current revenue growth of Voronoi? | Voronoi revenue growth (NTM/LTM) is 182%. |
| What is the current EV/Revenue multiple of Voronoi? | Current revenue multiple of Voronoi is 121.2x. |
| Is Voronoi profitable? | Yes, Voronoi is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Voronoi? | Voronoi's last 12 months EBITDA is -$17.5M. |
| What is Voronoi's EBITDA margin? | Voronoi's last 12 months EBITDA margin is -157%. |
| What is the current EV/EBITDA multiple of Voronoi? | Current EBITDA multiple of Voronoi is -77.1x. |
| What is the current FCF of Voronoi? | Voronoi's last 12 months FCF is -$14.6M. |
| What is Voronoi's FCF margin? | Voronoi's last 12 months FCF margin is -131%. |
| What is the current EV/FCF multiple of Voronoi? | Current FCF multiple of Voronoi is -92.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
